X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11168) 11168
Book Review (1279) 1279
Publication (795) 795
Book Chapter (56) 56
Conference Proceeding (28) 28
Dissertation (7) 7
Presentation (4) 4
Magazine Article (3) 3
Book / eBook (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8406) 8406
ophthalmology (7531) 7531
humans (7248) 7248
intravitreal injections (5509) 5509
male (4988) 4988
female (4689) 4689
aged (3436) 3436
bevacizumab (3222) 3222
middle aged (3209) 3209
ranibizumab (2875) 2875
vascular endothelial growth factor a - antagonists & inhibitors (2604) 2604
macular degeneration (2399) 2399
tomography, optical coherence (2272) 2272
treatment outcome (2264) 2264
intravitreal injection (2063) 2063
angiogenesis inhibitors - therapeutic use (2058) 2058
retrospective studies (1966) 1966
angiogenesis inhibitors - administration & dosage (1947) 1947
aged, 80 and over (1877) 1877
visual acuity (1843) 1843
animals (1816) 1816
fluorescein angiography (1776) 1776
eye diseases (1732) 1732
endothelial growth-factor (1611) 1611
visual acuity - physiology (1594) 1594
follow-up studies (1582) 1582
vascular endothelial growth factor (1552) 1552
adult (1459) 1459
macular edema - drug therapy (1411) 1411
genetic structures (1320) 1320
retina (1256) 1256
injection (1248) 1248
diabetic retinopathy (1195) 1195
prospective studies (1181) 1181
intravitreal bevacizumab (1174) 1174
sense organs (1070) 1070
care and treatment (1053) 1053
macular edema (1034) 1034
optical coherence tomography (1023) 1023
choroidal neovascularization - drug therapy (967) 967
choroidal neovascularization (942) 942
injections (900) 900
antibodies, monoclonal, humanized - therapeutic use (883) 883
vitrectomy (873) 873
photodynamic therapy (861) 861
therapy (860) 860
age-related macular degeneration (851) 851
diabetic retinopathy - drug therapy (840) 840
wet macular degeneration - drug therapy (836) 836
antibodies, monoclonal, humanized - administration & dosage (831) 831
diabetic macular edema (821) 821
medicine & public health (803) 803
edema (797) 797
antibodies, monoclonal, humanized (794) 794
macular degeneration - drug therapy (774) 774
neovascularization (772) 772
triamcinolone (759) 759
pharmacology & pharmacy (756) 756
retinopathy (736) 736
surgery (732) 732
analysis (731) 731
glucocorticoids - administration & dosage (722) 722
macular edema - etiology (706) 706
eye (685) 685
vitreous body (684) 684
triamcinolone acetonide (675) 675
diabetes (674) 674
endophthalmitis (668) 668
time factors (666) 666
retina - pathology (647) 647
avastin (619) 619
degeneration (607) 607
rabbits (606) 606
research (594) 594
abridged index medicus (590) 590
risk factors (584) 584
disease models, animal (583) 583
drug therapy (558) 558
physiological aspects (556) 556
angiogenesis inhibitors - adverse effects (554) 554
retinal vein occlusion (538) 538
intraocular pressure (527) 527
intravitreal triamcinolone (526) 526
efficacy (525) 525
patients (523) 523
visual acuity - drug effects (519) 519
safety (512) 512
vegf (510) 510
fundus oculi (504) 504
intravitreal (499) 499
macular edema - physiopathology (497) 497
retinal vein occlusion - drug therapy (496) 496
verteporfin (495) 495
antibodies, monoclonal - administration & dosage (476) 476
ranibizumab - administration & dosage (476) 476
glaucoma (475) 475
macular edema - diagnosis (473) 473
aflibercept (466) 466
rats (461) 461
age (458) 458
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10215) 10215
German (313) 313
Korean (222) 222
French (215) 215
Spanish (70) 70
Japanese (28) 28
Russian (28) 28
Turkish (28) 28
Chinese (24) 24
Polish (21) 21
Czech (14) 14
Portuguese (13) 13
Romanian (13) 13
Hungarian (7) 7
Slovenian (2) 2
Swedish (2) 2
Danish (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, ISBN 9789814571463
Intravitreal injections (injections into the eye) are a new form of treatment for various conditions such as age-related macular degeneration, diabetic eye... 
Eye | Vision disorders | Intravitreal Injections | therapy | methods | nursing | Ophthalmology | Eye Diseases | Diseases
Web Resource
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 6, pp. 1257 - 1262
Journal Article
Ophthalmology, ISSN 0161-6420, 01/2014, Volume 121, Issue 1, pp. 193 - 201
Journal Article
Journal Article
Journal Article
Retina, ISSN 0275-004X, 09/2011, Volume 31, Issue 8, pp. 1525 - 1533
Purpose: To determine the rate of postinjection endophthalmitis and compare microbial etiology and outcomes in office-based injection-related endophthalmitis... 
viridans streptococci | alpha-hemolytic streptococcus | triamcinolone acetonide | bevacizumab | endophthalmitis | intravitreal injection | ranibizumab | BACTERIAL-CONTAMINATION | INTRAOCULAR INFLAMMATION | TRIAMCINOLONE ACETONIDE INJECTION | ACUTE-ONSET ENDOPHTHALMITIS | RISK-FACTORS | BEVACIZUMAB AVASTIN INJECTION | NONINFECTIOUS ENDOPHTHALMITIS | MACULAR DEGENERATION | CATARACT-SURGERY | OPHTHALMOLOGY | INFECTIOUS ENDOPHTHALMITIS | Eye Infections, Bacterial - physiopathology | Glucocorticoids - administration & dosage | Humans | Middle Aged | Male | Aptamers, Nucleotide - administration & dosage | Eye Infections, Bacterial - diagnosis | Bevacizumab | Incidence | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Eye Infections, Bacterial - microbiology | Ranibizumab | Aged, 80 and over | Streptococcal Infections - physiopathology | Adult | Endophthalmitis - diagnosis | Female | Retrospective Studies | Vitreous Body - microbiology | Visual Acuity - physiology | Triamcinolone Acetonide - administration & dosage | Intravitreal Injections - adverse effects | Streptococcal Infections - microbiology | Risk Factors | Endophthalmitis - physiopathology | Viridans Streptococci - isolation & purification | Streptococcal Infections - diagnosis | Endophthalmitis - microbiology | Aged | Retinal Diseases - drug therapy | Index Medicus
Journal Article
Retina, ISSN 0275-004X, 07/2016, Volume 36, Issue 7, pp. 1349 - 1356
Journal Article
Retina, ISSN 0275-004X, 2014, Volume 34, Issue 5, pp. 943 - 950
Journal Article
Retina, ISSN 0275-004X, 11/2011, Volume 31, Issue 10, pp. 2032 - 2036
Purpose: Endophthalmitis after intravitreal injection is a serious complication. There are limited data to support the use of postinjection antibiotics to... 
Anti-vascular endothelial growth factor | Antibiotics | Intravitreal injection | Complications | Intraocular inflammation | Endophthalmitis | Triamcinolone | intraocular inflammation | TRIAMCINOLONE ACETONIDE INJECTION | complications | BEVACIZUMAB AVASTIN | intravitreal injection | anti-vascular endothelial growth factor | OPHTHALMOLOGY | AGENTS | endophthalmitis | antibiotics | triamcinolone | RANIBIZUMAB | STERILE ENDOPHTHALMITIS | Anti-Infective Agents, Local - therapeutic use | Glucocorticoids - administration & dosage | Intravitreal Injections | Humans | Middle Aged | Male | Antibiotic Prophylaxis | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Anti-Bacterial Agents - therapeutic use | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Eye Infections, Bacterial - microbiology | Ranibizumab | Aged, 80 and over | Adult | Female | Retrospective Studies | Vitreous Body - microbiology | Triamcinolone Acetonide - administration & dosage | Endophthalmitis - prevention & control | Aqueous Humor - microbiology | Eye Infections, Bacterial - prevention & control | Bacteria - isolation & purification | Endophthalmitis - microbiology | Vancomycin - therapeutic use | Aged | Retinal Diseases - drug therapy | Ceftazidime - therapeutic use | Index Medicus | anti-vascular endothelial growth factor (VEGF) | Intravitreal Injection | Intraocular Inflammation
Journal Article
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 1/2008, Volume 246, Issue 1, pp. 81 - 87
Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized by macular edema and/or... 
Angiogenesis | Intravitreal bevacizumab | Medicine & Public Health | Choroidal neovascularization | Age-related macular degeneration | Proliferative diabetic retinopathy | Diabetic macular edema | Ophthalmology | Safety | intravitreal bevacizumab | PHOTODYNAMIC THERAPY | choroidal neovascularization | angiogenesis | COHERENCE TOMOGRAPHY FINDINGS | BARRIER | MACULAR DEGENERATION | VERTEPORFIN | PHARMACOKINETICS | safety | PEGAPTANIB | GROWTH-FACTOR APTAMER | OPHTHALMOLOGY | age-related macular degeneration | proliferative diabetic retinopathy | diabetic macular edema | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | BREAKDOWN | Diabetic Retinopathy - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - drug therapy | Bevacizumab | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Time Factors | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Retinal Vein Occlusion - physiopathology | Macular Degeneration - physiopathology | Treatment Outcome | Visual Acuity | Choroidal Neovascularization - physiopathology | Retreatment | Injections | Retinal Vein Occlusion - drug therapy | Macular Edema - physiopathology | Macular Edema - drug therapy | Aged | Endothelial growth factors | Safety and security measures | Angiogenesis inhibitors | Index Medicus
Journal Article